Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Nvs crawled time : 11:00 save search
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
REGN | $893.99 -0.8% -0.84% 450K
|
Health Technology
|
| O: -1.94%
H: 0.43%
C: -0.34%
OCUL | News | $5.86 -22.69% -29.35% 6.1M
|
Health Technology
|
| O: -1.03%
H: 3.66%
C: 1.7%
ocular key leaders
Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
Published: 2024-04-11 (Crawled : 11:00) - globenewswire.com
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 0.32%
H: 0.04%
C: -0.56%
ARVN | $34.29 2.51% 2.48% 800K
|
Health Technology
|
| O: 8.28%
H: 0.56%
C: -4.75%
arv-766 protac license cancer treatment global protein for commercialization agreement
Carisma Therapeutics Announces Changes to its Board of Directors
Published: 2024-04-01 (Crawled : 11:00) - prnewswire.com
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 0.47%
H: 0.23%
C: -0.99%
CRIS | $15.22 -4.58% -6.62% 20K
|
Health Technology
|
| O: 0.7%
H: 16.87%
C: 16.87%
therapeutics
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
Published: 2024-03-27 (Crawled : 11:00) - biospace.com/
CRBU | $3.91 0.0% 1.1M
|
Health Technology
|
| O: 1.58%
H: 0.58%
C: -0.39%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 0.24%
H: 0.42%
C: 0.4%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.49%
H: 0.84%
C: -0.07%
TGTX | News | $13.99 1.23% 1.29% 3.1M
|
Health Technology
|
| O: 0.71%
H: 0.39%
C: 0.13%
DTIL | $10.72 -6.86% -6.87% 70K
|
Health Technology
|
| O: 0.39%
H: 4.22%
C: 1.41%
precision business year update financial results
Global Dermatological Drugs Market Set to Surpass US$30 Billion with Advanced Nanotechnology and Aging Population Fostering Growth
Published: 2024-02-28 (Crawled : 11:00) - prnewswire.com
ROIV | $10.36 -0.77% -0.68% 3.4M
|
Manufacturing
|
| O: -0.76%
H: 0.51%
C: 0.0%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 0.05%
H: 0.06%
C: -0.95%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: 0.0%
ABBV | News | $164.66 0.25% -0.14% 3.6M
|
Health Technology
|
| O: 0.6%
H: 0.02%
C: -1.03%
global set dermatological advanced growth market
Opthea Strengthens Team with Key Clinical and Regulatory Hires
Published: 2024-02-01 (Crawled : 11:00) - globenewswire.com
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 1.55%
H: 0.79%
C: 0.25%
ALC | $78.47 -0.67% 0.61% 700K
|
Health Technology
|
| O: 0.24%
H: 1.54%
C: 1.46%
OPT | $3.4 0.29% 2.7K
|
Health Technology
|
| O: -0.74%
H: 6.84%
C: 2.6%
key
Tyrosine Kinase Inhibitors Market to Grow at a CAGR of 8.42% between 2023 to 2028; Industry Trends, Driving Forces, Challenges & Market Forecast | Technavio
Published: 2024-01-25 (Crawled : 11:00) - prnewswire.com
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: -1.23%
H: 1.34%
C: 1.34%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -3.67%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: -0.44%
H: 0.19%
C: -0.08%
ABBV | News | $164.66 0.25% -0.14% 3.6M
|
Health Technology
|
| O: -1.92%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: -0.14%
H: 0.77%
C: 0.77%
market
Advancing Melanoma Therapeutics: Global Market Insights and In-depth Analysis by BCC Research
Published: 2024-01-12 (Crawled : 11:00) - prnewswire.com
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: 2.07%
H: 0.0%
C: -0.06%
ERAS | $1.79 -2.72% -2.51% 650K
|
|
| O: 0.0%
H: 4.62%
C: -1.03%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: -0.16%
H: 0.43%
C: 0.02%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: 0.25%
H: 0.36%
C: 0.1%
AMGN | $262.75 -0.5% -0.49% 1.4M
|
Health Technology
|
| O: 0.71%
H: 0.56%
C: 0.42%
melanoma research global market
OTC Markets Group Welcomes Sandoz Group AG to OTCQX
Published: 2023-10-04 (Crawled : 11:00) - globenewswire.com
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: -3.27%
H: 0.0%
C: 0.0%
otcqx group
ACELYRIN, INC. Scales for Continued Late-Stage Growth with The Appointment of Dr. Shephard Mpofu as Senior Vice President of Development
Published: 2023-10-03 (Crawled : 11:00) - globenewswire.com
SLRN | $4.88 -2.79% -2.66% 1.2M
|
|
| O: -0.2%
H: 0.0%
C: -3.59%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: -1.6%
H: 0.36%
C: -0.46%
growth
Inflammatory Bowel Disease Market to grow by USD 7,687.43 million from 2022 to 2027; The increasing demand for biologics and targeted therapies drives the market - Technavio
Published: 2023-08-16 (Crawled : 11:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: 5.46%
H: 0.0%
C: -2.87%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.67%
H: 0.0%
C: 0.0%
VTRS | $11.12 0.18% 0.09% 2.3M
|
Health Technology
|
| O: -0.99%
H: 1.45%
C: 1.36%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: -0.2%
H: 0.34%
C: -0.26%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: -0.77%
H: 0.79%
C: 0.17%
BAX | $39.65 0.33% -1.19% 2.3M
|
Health Technology
|
| O: -0.4%
H: 0.73%
C: -0.24%
ABBV | News | $164.66 0.25% -0.14% 3.6M
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
ABT | News | $105.27 -0.6% -0.38% 5.9M
|
Health Technology
|
| O: -1.36%
H: 0.88%
C: 0.07%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: -1.33%
H: 0.0%
C: 0.0%
disease market
Coherus to Acquire Surface Oncology
Published: 2023-06-16 (Crawled : 11:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.75%
H: 0.14%
C: 0.14%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 1.03%
H: 0.29%
C: -0.59%
SURF | $1.07 -0.93% -1.41% 0
|
Health Technology
|
| O: 31.08%
H: 2.06%
C: -18.38%
CHRS | $2.0 -6.98% -8.04% 1.8M
|
Health Technology
|
| O: -12.06%
H: 0.42%
C: -12.87%
acquire
KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMA
Published: 2023-06-08 (Crawled : 11:00) - prnewswire.com
DAWN 4 | $15.75 6.06% 5.77% 1.6M
|
Professional, Scientific, and T...
|
| O: -0.69%
H: 0.0%
C: -7.55%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 1.26%
H: 1.08%
C: 0.91%
KZIA | $0.3462 0.58% 2.27% 270K
|
Health Technology
|
| O: 1.57%
H: 3.07%
C: 1.53%
paxalisib therapeutics study
Telix Reports Q1 2023 Financial Results: Delivers First $100M Revenue Quarter
Published: 2023-04-17 (Crawled : 11:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 0.47%
H: 0.01%
C: -0.38%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.07%
H: 0.24%
C: -0.71%
financial
Ulcerative Colitis Drug Global Market Report 2022: Increasing Prevalence of Ulcerative Colitis and Inflammatory Bowel Diseases Bolsters Sector
Published: 2023-04-07 (Crawled : 11:00) - prnewswire.com
TAK | News | $13.16 0.08% 0.53% 1.2M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $164.66 0.25% -0.14% 3.6M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
BHC | $8.6 -0.69% 0.0% 2.2M
|
Health Technology
| Email alert
Add to watchlist
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
| Email alert
Add to watchlist
drug report global market
Clostridium Diagnostics Market to grow at a CAGR of 13.69% from 2022 to 2027, Driven by the growing prevalence of CDI - Technavio
Published: 2023-03-27 (Crawled : 11:00) - prnewswire.com
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: 0.55%
H: 1.46%
C: -0.08%
TMO | News | $541.52 -1.05% -0.1% 1.8M
|
Health Technology
|
| O: 0.99%
H: 0.78%
C: -0.37%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 6.51%
H: 1.75%
C: 1.4%
TRIB | $1.88 2.17% -0.55% 23K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -6.32%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: 1.46%
H: 0.53%
C: -0.25%
growing diagnostics market
Dermatitis Global Market Research Report 2023: An $8.57 Billion Market by 2027 - Long-term Forecasts to 2032
Published: 2023-03-20 (Crawled : 11:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: -0.06%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.98%
H: 0.0%
C: 0.0%
ALPMY | $9.47 0.11% -1.11% 520K
|
Manufacturing
|
| O: -0.5%
H: 1.38%
C: 1.23%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 0.78%
H: 0.74%
C: 0.72%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: 1.38%
H: 1.16%
C: 1.13%
ABBV | News | $164.66 0.25% -0.14% 3.6M
|
Health Technology
|
| O: 0.19%
H: 1.18%
C: 1.04%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 0.4%
H: 0.0%
C: 0.0%
report dermatitis research global market
Cervical Cancer Drugs Global Market Research Report 2023 Featuring F. Hoffmann-La Roche, Hetero, GSK, Eli Lilly, Pfizer, Alnylam, Allergan, Biocon, Bristol-Myers Squibb, and Novartis
Published: 2023-02-24 (Crawled : 11:00) - prnewswire.com
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: -1.25%
H: 0.59%
C: 0.59%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: -0.25%
H: 0.03%
C: -0.81%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -0.46%
H: 0.38%
C: -1.34%
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: -0.41%
H: 0.15%
C: -1.31%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: -0.98%
H: 0.16%
C: -0.55%
research global report novartis cancer market
Insights on the Pharmaceutical API Manufacturing Global Market to 2032: North America was the Largest Region in 2022
Published: 2023-02-22 (Crawled : 11:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: 0.48%
H: 0.0%
C: -2.77%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.53%
H: 1.82%
C: 1.82%
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: -0.48%
H: 0.14%
C: 0.14%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 0.98%
H: 0.03%
C: -1.06%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: -0.91%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.37%
H: 1.18%
C: 0.11%
ALB | News | $111.8 -2.26% -0.05% 2M
|
Process Industries
|
| O: 0.43%
H: 1.9%
C: 1.42%
ABBV | News | $164.66 0.25% -0.14% 3.6M
|
Health Technology
|
| O: -0.66%
H: 0.76%
C: -0.22%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: 0.04%
H: 0.04%
C: -1.11%
america global market
Attention deficit hyperactivity disorder (ADHD) drugs market size to increase by USD 9.61 billion from 2020 to 2025; North America to account for 40% of market growth - Technavio
Published: 2023-02-20 (Crawled : 11:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
| Email alert
Add to watchlist
america growth market
Gainers vs Losers
| 60% | 40% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.